Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 4 February 2011 at 11.45
Notification according to Chapter 2, Section 10 of the Finnish Securities Market
Act
Biotie Therapies Corp. ("Company" or "Biotie") has gained knowledge of the
notifications regarding changes in holdings in accordance with Chapter 2,
Section 9 of the Finnish Securities Markets Act, described below.
The notifications received by the Company concern the changes in holdings of
Invesco Limited (through Invesco Fund Managers Limited) ("Invesco").
The mentioned change in holdings is related to the Combination Agreement entered
into on 10 January 2011 among the Company, Synosia Therapeutics Holding AG
("Synosia") as well as Synosia's shareholders and warrant holders, described in
more detail in a stock exchange release issued on 11 January 2011. As described
in detail in Biotie's stock exchange release issued on 2 February 2011, Biotie's
Extraordinary General Meeting has on 1 February 2011 passed resolutions
necessary for the completion of the transaction and the other prerequisites for
the completion of the transaction have been fulfilled, and the Company has
issued 161,448,371 shares to the shareholders and warrant holders of Synosia as
consideration for the entire issued share capital and outstanding warrants of
Synosia (the "Transaction"). In connection with the Transaction, the Company
issued 14,912,155 new shares to Synosia to be held in treasury and used to
satisfy future potential exercise of Synosia's options. The new shares have been
registered on 3 February 2011.
As a consequence of the Transaction Invesco's holding of shares and votes in the
Company decreased below 5 % as follows:
Name Number of Number of Number of Share of Share of
shares before voting rights shares and share capital voting rights
Transaction before voting rights after after
Transaction after Transaction Transaction
Transaction (%) (%)
Invesco 14,432,000 14,432,000 14,432,000 4,10 4,10
Limited
(through
Invesco
Fund
Managers
Limited)
On the date hereof, the registered number of shares in Biotie Therapies Corp. is
352,364,457. Of these shares 29,659,239 are held by the Company or its group
companies.
Turku, 4 February 2011
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail:virve.nurmi(at)biotie.com
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via Thomson Reuters ONE
[HUG#1485493]
Unternehmensinformation / Kurzprofil:
Datum: 04.02.2011 - 10:45 Uhr
Sprache: Deutsch
News-ID 51095
Anzahl Zeichen: 3632
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 187 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
